Myriad™ Augmented Soft Tissue Reconstruction Registry
NCT05243966
This study is recruiting at 6 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Abdominal Wound Dehiscence
- Necrotizing Soft Tissue Infection
- Lower Extremity Wound
- Pilonidal Sinus
- Anal Fistula
- Hidradenitis Suppurativa
- Pressure Injury
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Aroa Biosurgery Limited
- Last updated on ClinicalTrials.gov
- July 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Asencion Sacred Heart · Pensacola, FL
Georgia · 1
- Northeast Georgia Medical Center, Inc. · Gainesville, GA
Louisiana · 1
- University Medical Center · New Orleans, LA
Maryland · 1
- Sinai Hospital of Baltimore · Baltimore, MD
Pennsylvania · 1
- Lancaster General Hospital · Lancaster, PA
Wisconsin · 1
- The Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.